Abstract:A novel layer by layer (LbL) assembled structure with phosphorylcholine groups was fabricated to improve the hemocompatibility of paclitaxel/chitosan (PTX/CS) nanofibers (NF) coatings The random copolymers with phosphorylcholine groups poly (2-methacryloyloxy-ethylphosphorylcholine-co-methacrylicacid) (PMAs) were synthesized through free radical polymerization and then first PMA layer formed on PTX/CS NF coatings via electrostatic interactions. After that CS polycation and PMA polyanion thin films LbL formed on PTX/CS NF coatings. The LbL structure was confirmed by X-ray photoelectron spectroscopy (XPS) and water contact angle. The drug release in vitro indicated that the PMA modified PTX/CS NF coatings (PTX/CS-PMA NF coatings) showed a sustained slower release of PTX drug. The LbL coatings containing phosphorylcholine groups could significantly reduce proteins adsorption, platelets adhesion and cell adhesion. They showed a lower platelet (about 6%) and protein (30-40%) (bovine serum albumin, BSA; bovine plasma fibrinogen, Fg) adhesion. Meanwhile, the adhesion of human umbilical vein endothelial cells (HUVECs) was also found reduced. These results demonstrate that the preparation of PMA modified coatings is a simple strategy to improve the hemocompatibility of PTX/CS NF coatings, has good potential for application in blood-contacting materials and devices. Statement of significance: We develop a simple method to improve the hemocompatibility of paclitaxel/chitosan (PTX/CS) nanofibers (NF) coatings, which can significantly reduce the protein adsorption, and the adhesion of cells and platelets. Using layer by layer (LbL) assembly with PMA polyanion and CS polycation, multilayered PMA/CS films formed on the PTX/CS NF coatings. The X-ray photoelectron spectroscopy (XPS) and water contact angle characterization demonstrated that a cell outer membrane mimetic structure was formed on the PTX/CS NF coatings. The hemocompatibility of modified surface was significantly improved as shown by 94% adhesion suppression for platelets and 60-70% adsorption suppression for bovine plasma fibrinogen (Fg) and bovine serum albumin (BSA). The drug release in vitro indicated that the PMA modified PTX/CS NF (PTX/CS-PMA) coatings had a sustained drug release. Thus this paper provides a facile method for fabricating cell outer membrane mimetic structure which can improve hemocompatibility of blood-contacting material surfaces.

Improvement of Hemocompatibility of Polycaprolactone Film Surfaces with Zwitterionic Polymer Brushes.

PC Technology Improving the Hemocompatibility of Polymer Membranes Developed for Biomedical Application

Surface Functionalization of Polycaprolactone Films Via Surface-Initiated Atom Transfer Radical Polymerization for Covalently Coupling Cell-Adhesive Biomolecules.

Surface Modification of Polycaprolactone Membrane Via Layer-By-Layer Deposition for Promoting Blood Compatibility

Surface Modification of Polycaprolactone Membrane Via Aminolysis and Biomacromolecule Immobilization for Promoting Cytocompatibility of Human Endothelial Cells.

Surface Modification of Polycaprolactone Scaffold With Improved Biocompatibility and Controlled Growth Factor Release for Enhanced Stem Cell Differentiation

Characterization on Modification and Biocompatibility of PCL Scaffold Prepared with Near-field Direct-writing Melt Electrospinning

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Surface modification of polycaprolactone with poly(methacrylic acid) and gelatin covalent immobilization for promoting its cytocompatibility.

PCL Film Surfaces Conjugated with P(DMAEMA)/gelatin Complexes for Improving Cell Immobilization and Gene Transfection.

Layer by Layer Assembled Phosphorylcholine Groups on Paclitaxel/chitosan Nanofibers Coatings for Hemocompatibility Improvement

Biocompatibility of Poly(ε-caprolactone) Scaffold Modified by Chitosan—The Fibroblasts Proliferation in vitro

Effect of Surface Grafted Hydroxyapatite on the Improved Performance of Hydroxyapatite/Poly(epsilon-caprolactone) Scaffold

Functionalization of polycarbonate surfaces by grafting PEG and zwitterionic polymers with a multicomb structure

Functionalization of PCL-based Nanofibers Loaded with Hirudin As Blood Contact Materials.

Preparation of multifunctional poly(l-lactic acid) film using heparin-mimetic polysaccharide multilayers: Hemocompatibility, cytotoxicity, antibacterial and drug loading/releasing properties.

Biocompatibility of Poly(e-caprolactone) Scaffold Modified by Chitosan— The Fibroblasts Proliferation in vitro

Biocompatibility of Poly(ε-caprolactone) Scaffold Modified by Chitosan—The Fibroblasts Proliferation in Vitro

Simultaneous enhancement of the strength and elongation of polycaprolactone: The role of chitosan-<i>graft</i>-polycaprolactone

Localized surface functionalization of polycaprolactone with atmospheric-pressure microplasma jet